Loading clinical trials...
Loading clinical trials...
The purpose of this study will be to analyze 13-valent pneumococcal vaccine given to healthy infants in Brazil for safety and tolerability, and to determine the immune response to the vaccines.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
NCT00980655 · Vaccines, Pneumococcal Conjugate Vaccine
NCT00574795 · Vaccines, Pneumococcal Conjugate Vaccine
NCT00475033 · Vaccines, Pneumococcal Conjugate Vaccine
NCT00500357 · Vaccines, Pneumococcal Conjugate Vaccine
Curitiba
Florianópolis
Sau Paulo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions